Disease: Prostate carcinoma ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 Biomarker disease BEFREE Our previous studies found high expression and oncologic role of high-mobility group nucleosome binding domain 5 (<i>HMGN5</i>) in prostate cancer. 31314587 2019
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 AlteredExpression disease BEFREE Correlation analysis also showed that HMGN5 expression levels were significantly inversely correlated with the miR-340 expression in prostate cancer tissues. 26394192 2016
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 Biomarker disease BEFREE The present study suggests that HMGN5 is a potential biomarker for treating prostate cancer, and patients with a high level HMGN5 will benefit from gemcitabine treatment. 25572120 2015
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 AlteredExpression disease BEFREE We have previously found that HMGN5 is upregulated in prostate cancer and its downregulation had been demonstrated to induce apoptosis and G2-M cell cycle arrest. 25307178 2015
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 Biomarker disease BEFREE The androgen-dependent LNCaP human prostate cancer cells were infected with siRNA-HMGN5. 22504871 2012
CUI: C0600139
Disease: Prostate carcinoma
Prostate carcinoma 		0.060 Biomarker disease BEFREE In conclusion, knockdown of NSBP1 causes a statistically significant inhibition of the in vitro and in vivo growth of the PCa cell line DU145. 20531280 2010